-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kyverna Therapeutics Inc (KYTX)
-
-
-
-
-
-
-
Kyverna Therapeutics, Inc. (KYTX) Tops Q3 EPS by 17c
-
-
-
-
-
-
-
William Blair Starts Kyverna Therapeutics Inc (KYTX) at Outperform
-
-
-
-
-
-
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
-
-
-
-
-
-
-
ROSEN, A TOP-RANKED LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
-
-
-
-
-
-
-
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
-
-
-
-
-
-
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
-
445,863 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

